0001535955 2026-06-09 2026-06-09 0001535955 1 2026-06-09 2026-06-09 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001535955 Lipocine Inc. N/A false S-8 Lipocine Inc. Equity Common Stock, $0.0001 par value per share, to be issued under the Lipocine Inc. Sixth Amended and Restated Stock and Incentive Plan true 663418 2.25 1492690.50 0.0001381 206.14 1492690.50 206.14 0.00 206.14 Pursuant to Rule 416(a), this registration statement covers, in addition to the number of shares of Lipocine Inc., a Delaware corporation (the "Company" or the "Registrant"), common stock, par value $0.0001 per share (the "Common Stock"), stated above, options and other rights to purchase or acquire the shares of Common Stock covered by this registration statement and, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), any shares of Common Stock that become issuable under the Lipocine Inc. Sixth Amended and Restated 2014 Stock and Incentive Plan (the "Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction that results in an increase in the number of the Registrant's outstanding shares of Common Stock. Pursuant to Securities Act Rule 457(h), the maximum offering price, per share and in the aggregate, and the registration fee were calculated based upon the average of the high and low prices of the Common Stock on June 2, 2026, as quoted on The Nasdaq Capital Market.